会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • ANGIOGENIC TYROSYL TRNA SYNTHETASE COMPOSITIONS AND METHODS
    • 抗原型酪氨酸TRNA合成酶组合物及方法
    • WO2007064941A2
    • 2007-06-07
    • PCT/US2006046106
    • 2006-12-01
    • SCRIPPS RESEARCH INSTYANG XIANG-LEI
    • YANG XIANG-LEI
    • C12N9/22
    • C12N9/93
    • The present invention provides an isolated tyrosyl tRNA synthetase (TyrRS) polypeptide variant which comprises (a) a Rossmann fold region or a portion thereof, preferably including an 5 coil; and (b) an anticodon recognition domain or portion thereof, preferably including an 14 coil. Preferably, the 5 coil and the 14 coil have a greater spatial separation in the tertiary structure of the variant compared to the corresponding spatial separation in native human TyrRS. The variant preferably comprises an amino acid residue sequence identity of at least about 50 % compared to the amino acid residue sequence of human TyrRS (SEQ ID NO: 3), includes at least one non-conservative amino acid residue substitution relative to the amino acid residue sequence of human TyrRS, and preferably presents an exposed ELR motif in the 5 coil on an external portion of the tertiary structure of the polypeptide. A preferred TyrRS protein variant comprises the amino acid residue sequence of SEQ ID NO: 4 or a portion thereof. The proteins and protein fragments of the invention are angiogenic and are useful for stimulating angiogenesis in mammalian tissues.
    • 本发明提供了分离的酪氨酰tRNA合成酶(TyrRS)多肽变体,其包含(a)Rossmann折叠区域或其部分,优选包括5个线圈; 和(b)反密码子识别结构域或其部分,优选包含14个线圈。 优选地,与天然人类TyrRS中相应的空间分离相比,5线圈和14线圈在变体的三级结构中具有更大的空间分离。 与人TyrRS(SEQ ID NO:3)的氨基酸残基序列相比,该变体优选包含至少约50%的氨基酸残基序列同一性,包括相对于氨基酸至少一个非保守氨基酸残基取代 人TyrRS的残基序列,并且优选在5线圈中在多肽的三级结构的外部部分上暴露的ELR基序。 优选的TyrRS蛋白质变体包含SEQ ID NO:4的氨基酸残基序列或其部分。 本发明的蛋白质和蛋白质片段是血管生成的并且可用于刺激哺乳动物组织中的血管发生。